Despite the view that some have expressed, including myself, that management is overpaid and underperforming, this announcement stresses that Drs in the field see R327 and appear very excited about its future need for development.
There is going to be some form of fast track involved here. If R327 can kill this major problem super bug, it will be used in patients who may die without it because other treatments have not worked
Thats some kill rate
Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $95.16M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.5¢ | 33.0¢ | $90.83K | 275.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 93396 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 12634 | 2 |
View Market Depth
| Last trade - 15.59pm 15/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |